Works by Rackley, Briana B.

Real-World Evidence Shows Clinicians Appropriately Use the Prognostic 40-Gene Expression Profile (40-GEP) Test for High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients.

Published in:

Cancer Investigation, 2022, v. 40, n. 10, p. 911, doi. 10.1080/07357907.2022.2116454

By:

• Hooper, Perry B.;
• Farberg, Aaron S.;
• Fitzgerald, Alison L.;
• Siegel, Jennifer J.;
• Rackley, Briana B.;
• Prasai, Anesh;
• Kurley, Sarah J.;
• Goldberg, Matthew S.;
• Litchman, Graham H.

Publication type:

Article